StockNews.AI
CDNA
StockNews.AI
133 days

CareDx to Report First Quarter 2025 Financial Results

1. CareDx (CDNA) scheduled Q1 2025 financial results release on April 30. 2. A conference call for results discussion will follow at 1:30 PM PT.

Earnings
-4.29%Current Return
VS
-1.57%S&P 500
$17.7204/08 07:14 AM EDTEvent Start
$16.9604/08 09:16 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Q1 reports can influence stock but depend on performance, similar to historical trends seen post-earnings releases.

How important is it?

Earnings results can significantly influence investor sentiment; however, no additional context provided.

Why Short Term?

Earnings reports typically impact stock prices immediately following the announcements.

Related Companies

VRTXREGNLABP
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the first quarter 2025 after market close on Wednesday, April 30, 2025. Company management will host a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Related News